Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
Gross Profit Over TimeStrong
Percentile Rank100
3Y CAGR+9.4%
5Y CAGR+13.4%
Year-over-Year Change
Revenue minus cost of goods sold
3Y CAGR
+9.4%/yr
vs +31.3%/yr prior
5Y CAGR
+13.4%/yr
Recent deceleration
Acceleration
-22.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
9 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $10.27B | +8.2% |
| 2024 | $9.49B | +10.3% |
| 2023 | $8.61B | +9.6% |
| 2022 | $7.85B | +17.7% |
| 2021 | $6.67B | +22.0% |
| 2020 | $5.47B | +51.3% |
| 2019 | $3.62B | +37.0% |
| 2018 | $2.64B | +19.2% |
| 2017 | $2.21B | +48.4% |
| 2016 | $1.49B | - |